← Evidence map

ArticleNature reviews. Clinical oncology2019

Why BRCA mutations are not tumour-agnostic biomarkers for PARP inhibitor therapy.

Nicola J Curtin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

19 papers cite it

2019
2020
2021
2022
2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 31582817